Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 2 Interventional Results available

Study Evaluating The Long-Term Safety And Efficacy Of Subcutaneous Bapineuzumab

ClinicalTrials.gov ID: NCT00916617

Public ClinicalTrials.gov record NCT00916617. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Apr 30, 2026, 7:13 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter, Open Label, Multiple Dose, Parallel Group Investigation Of The Long-term Safety, Tolerability, Reactogenicity, Pharmacokinetics And Pharmacodynamics Of Aab-001 Administered Subcutaneously In Subjects With Mild To Moderate Alzheimer's Disease

Study identification

NCT ID
NCT00916617
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 2
Lead sponsor
Pfizer
Industry
Enrollment
62 participants

Conditions and interventions

Interventions

  • bapineuzumab Drug

Drug

Eligibility (public fields only)

Age range
50 Years to 89 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 31, 2009
Primary completion
Aug 31, 2012
Completion
Aug 31, 2012
Last update posted
May 31, 2017

2009 – 2012

United States locations

U.S. sites
16
U.S. states
10
U.S. cities
14
Facility City State ZIP Site status
Banner Alzheimer's Institute Phoenix Arizona 85006
Pharmacology Research Institute Encino California 91316
Brain Matters Research Delray Beach Florida 33445
MD Clinical Hallandale Florida 33009
Palm Beach Neurology - Premiere Research Institute West Palm Beach Florida 33407
Neurostudies.net Decatur Georgia 30033
Dekalb Neurology Associates, LLC Lawrenceville Georgia 30045
NeuroStudies.net Lawrenceville Georgia 30046
Clinical Research Institute Wichita Kansas 67207
Monroe Community Hospital Rochester New York 14620
Rhode Island Mood and Memory Research Institute East Providence Rhode Island 02914
Butler Hospital Providence Rhode Island 02906
Texas Neurology, P.A. Dallas Texas 75214
The Memory Clinic Bennington Vermont 05201
University of Wisconsin, Department of Surgery Madison Wisconsin 53705
University of Wisconsin Madison Wisconsin 53792

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00916617, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 31, 2017 · Synced Apr 30, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00916617 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →